30th November 2021
- 0 comments
British Patient Capital has participated in Quell Therapeutics’ $156m Series B funding round. The deal is the first life sciences investment from Future Fund: Breakthrough, a £375m programme where British Patient Capital co-invests with private sector investors in innovative R&D-intensive UK companies.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.